Next StepAfter the phase I clinical trial is officially completed, Sinovac will start the application process with SFDA start of the Phase II study approved. The company is. Their summary report of the Phase I clinical study, planning and protocol for Phase II clinical trial and other relevant documents.
UNC School of Medicine: Les Lang, 919-843-9687 or. Duke University Medical Center Contact: Tracey Koepke, or 919-660-1301., dass.
If you are an member of the class, you can not later than the 8th Dec. 2008 ask that the Court of First appointing they lead plaintiff of the class. A main plaintiffs is a genus member acting on behalf of the another participant in leading the litigation. While your ability to get shares any recovery any recovery do not concerned by a decision whether or not looking for appointed main plaintiff lead plaintiff make major decisions the overall the overall recovery for the members. Dass.